期刊文献+

齐墩果酸滴丸的制备及质量标准研究 被引量:4

Preparation and Quality Standard of Oleanolic Acid Drop Pills
原文传递
导出
摘要 目的:制备齐墩果酸滴丸并建立其质量标准。方法:按常规方法制备滴丸,采用紫外分光光度法,以齐墩果酸为对照品,在210nm波长处测定齐墩果酸含量和齐墩果酸滴丸的溶出度。结果:制得的滴丸大小均匀、圆整光滑、硬度适中。齐墩果酸的检测浓度在4~120μg.mL-1范围内与吸光度呈良好线性关系(r=0.9998);平均加样回收率为99.56%,RSD=1.15%(n=6)。齐墩果酸滴丸30min时的溶出度为(76.2±1.94)%。结论:该制备方法简单,滴丸成形性好,质量可控,体外溶出度高。 OBJECTIVE: To prepare Oleanolic acid(OA) drop pills and establish its quality standard. METHODS: The drop pills were prepared by a routine method. The content of OA and the dissolution rates of OA drop pills were determined by UV spectrophotometry under a wavelength of 210 nm taking oleanolic acid as a control. RESULTS: The drop pills were well- distributed in size, smooth and glossy in appearance, mild in hardness. The linear range for OA was 4-- 120 μg · mL^-1(r = 0.999 8) with an average recovery of 99.56% (RSD = 1.15%, n = 6) . The dissolution rate of OA drop pills at 30 min was (76.1± 1.94)%. CONCLUSION: The preparation method of OA drop pills is simple, and the drop pills are well- shaped with controllable quality and high dissolution rate.
出处 《中国药房》 CAS CSCD 北大核心 2009年第9期666-667,共2页 China Pharmacy
关键词 齐墩果酸 滴丸 紫外分光光度法 溶出度 Oleanolic acid Drop pills UV spectrophotometry Dissolution rate
  • 相关文献

参考文献5

二级参考文献27

共引文献55

同被引文献21

  • 1陈亚军,杨祥良,赵晓玲,徐辉碧.齐墩果酸纳米悬浮液的制备[J].中国药学杂志,2006,41(12):924-927. 被引量:10
  • 2陈国广,徐元龙,李学明.5-氟尿嘧啶纳米粒的制备及其体外释药的研究[J].华西药学杂志,2006,21(5):436-439. 被引量:13
  • 3李平华.叶苷滴丸成型工艺研究[J].中国药房,2007,18(6):436-437. 被引量:6
  • 4颜磊,龚萍,袁林,蒋雪梅,夏之宁.具有油水分配系数测算功能的中药指纹图谱[J].色谱,2007,25(3):337-340. 被引量:8
  • 5Sultana N, Ata A. Oleanolic acid and related derivatives as medicinally important compounds[J]. J Enzyme Inhib Med Chem, 2008, 23(6): 739.
  • 6Liu J. Oleanolic acid and ursolic acid: research perspectives[J]. JEthnopharmacol,2005, 100(1-2) : 92.
  • 7Jeong DW, Kim YH, Kim HH, et al. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats[J]. Biopharm Drug Dispos, 2007, 28(2) : 51.
  • 8Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system[J]. Eur J Pharm Biopharm, 2006, 63(3): 288.
  • 9Maribel T, Maria JA, Madalena M, et al. Development and characterization of PLGA nanospheres and nanocap sules containing xanthone and 3-methoxyxanthone[J]. Eur J Pharm Biopham, 2005,59 ( 3 ) : 491.
  • 10中华人民共和国药典委员会.中华人民共和国药典(二部)[S].北京:化学工业出版社,2005.附录61~63.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部